Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
J Equine Vet Sci ; 138: 105103, 2024 Jul.
Article in English | MEDLINE | ID: mdl-38797250

ABSTRACT

Rhodococcus equi (R. equi), a gram-positive facultative intracellular pathogen, is a common cause of pneumonia in foals and represents a major cause of disease and death. The aim of the present study was to investigate the time-depended changes in White Blood Cells (WBC), basophils (Baso), neutrophils (Neu), lymphocytes (Lymf), monocytes (Mon), eosinophils (Eos), platelet (PLT) counts, fibrinogen (Fbg) concentration, interferon (IFN-α, IFN-γ) and interleukins (IL-2 and IL-10) in foals with clinical R. equi pneumonia. The main treatment was with azithromycin-rifampicin for 14 days. Blood was sampled prior to, 7 and 14 days after starting therapy. Treatment was associated with significantly decreased counts of WBC, (25.6 ± 6.7 and 14.2 ± 2,7 × 103/ml), Neu (18.6 ±6.2 and 10.7 ± 3.1 × 103/ml), Mon (1.5 ± 0.5 and 0.9 ± 0.2 × 103/ml) and Fbg (539 ± 124 and 287 ± 26 g/dl) between day 0 and day 14. IL-2 and IL-10 concentrations were significantly increased (P = 0.028, P = 0.013, respectively) after treatment, whereas IFN-α and IFN-γ concentrations were not. The diagnostic potentials of INF-α, INF-γ, IL-2 and IL-10 per se seems not very high, however, the study suggests that the activity change of selected interleukins in the course of the disease may be associated with amelioration. We concluded that patterns of serum concentration changes of INF-α, INF-γ, IL-2 and IL-10 may help in the study of the innate immune response in foals during infection and treatment of R. equi pneumonia.


Subject(s)
Actinomycetales Infections , Anti-Bacterial Agents , Biomarkers , Horse Diseases , Rhodococcus equi , Animals , Horses/blood , Horse Diseases/blood , Horse Diseases/drug therapy , Horse Diseases/microbiology , Horse Diseases/immunology , Actinomycetales Infections/veterinary , Actinomycetales Infections/drug therapy , Actinomycetales Infections/blood , Actinomycetales Infections/immunology , Actinomycetales Infections/microbiology , Anti-Bacterial Agents/therapeutic use , Biomarkers/blood , Pneumonia, Bacterial/drug therapy , Pneumonia, Bacterial/veterinary , Pneumonia, Bacterial/blood , Pneumonia, Bacterial/immunology , Pneumonia, Bacterial/microbiology , Azithromycin/therapeutic use , Female , Male
SELECTION OF CITATIONS
SEARCH DETAIL
...